Analysts at Bank of America raised their price target for Dr Pepper Snapple Group Inc. on Friday from $70 to $75, but maintained a Neutral rating. Specialist Bryan Spillane thinks Dr Pepper Snapple's valuation -- lower than those for several of its bigger competitors -- is justified, as its main contenders, The Coca-Cola Co and PepsiCo, Inc. , enjoy larger benefits derived from their scales and "more diversified business models."